Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Polosan, M.
2008.
Associations médicamenteuses : que dire aujourd’hui ?.
L'Encéphale,
Vol. 34,
Issue. ,
p.
S249.
Liu, Xiaomeng
De Haan, Saskia
and
Liu, Xiaomeng
2009.
Cochrane Database of Systematic Reviews.
Mattai, Anand K
Hill, Julia L
and
Lenroot, Rhoshel K
2010.
Treatment of early-onset schizophrenia.
Current Opinion in Psychiatry,
Vol. 23,
Issue. 4,
p.
304.
Vieta, Eduard
Owen, Randall
Baudelet, Christine
McQuade, Robert D.
Sanchez, Raymond
and
Marcus, Ronald N.
2010.
Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Current Medical Research and Opinion,
Vol. 26,
Issue. 6,
p.
1485.
Howard, A.K.
and
Zurowski, M.
2010.
Encyclopedia of Movement Disorders.
p.
282.
Bénézech, Michel
Chapenoire, Stéphane
Miras, Alain
and
Favarel-Garrigues, Jean-Claude
2012.
Interrogations diagnostiques et thérapeutiques sur un cas de manie confuse d’évolution létale.
Annales Médico-psychologiques, revue psychiatrique,
Vol. 170,
Issue. 5,
p.
330.
Canfrán-Duque, Alberto
Casado, María E.
Pastor, Óscar
Sánchez-Wandelmer, Jana
de la Peña, Gema
Lerma, Milagros
Mariscal, Paloma
Bracher, Franz
Lasunción, Miguel A.
and
Busto, Rebeca
2013.
Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro.
Journal of Lipid Research,
Vol. 54,
Issue. 2,
p.
310.
Doherty, Anne M.
and
Gaughran, Fiona
2014.
The interface of physical and mental health.
Social Psychiatry and Psychiatric Epidemiology,
Vol. 49,
Issue. 5,
p.
673.
Schneider, Carolina
Taylor, David
Zalsman, Gil
Frangou, Sophia
and
Kyriakopoulos, Marinos
2014.
Antipsychotics use in children and adolescents: An on-going challenge in clinical practice.
Journal of Psychopharmacology,
Vol. 28,
Issue. 7,
p.
615.
Abayomi, Olukayode
Amato, Davide
Bailey, Candace
Bitanihirwe, Byron
Bowen, Lynneice
Burshtein, Shimon
Cullen, Alexis
Fusté, Montserrat
Herrmann, Ana P.
Khodaie, Babak
Kilian, Sanja
Lang, Qortni A.
Manning, Elizabeth E.
Massuda, Raffael
Nurjono, Milawaty
Sadiq, Sarosh
Sanchez-Gutierrez, Teresa
Sheinbaum, Tamara
Shivakumar, Venkataram
Simon, Nicholas
Spiteri-Staines, Anneliese
Sirijit, Suttajit
Toftdahl, Nanna Gilliam
Wadehra, Sunali
Wang, Yi
Wigton, Rebekah
Wright, Susan
Yagoda, Sergey
Zaytseva, Yuliya
O'Shea, Anne
and
DeLisi, Lynn E.
2014.
The 4th Schizophrenia International Research Society Conference, 5–9 April 2014, Florence, Italy: A summary of topics and trends.
Schizophrenia Research,
Vol. 159,
Issue. 2-3,
p.
e1.
Laoutidis, Zacharias G.
and
Kioulos, Kanellos T.
2014.
Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice.
Psychopharmacology,
Vol. 231,
Issue. 22,
p.
4255.
Lambert, M.
and
Correll, C.
2015.
Sollen bei Prodromalstadien der Schizophrenie Antipsychotika zur Psychoseprävention eingesetzt werden? Pro.
Der Nervenarzt,
Vol. 86,
Issue. 11,
p.
1420.
Kahn, René S.
Sommer, Iris E.
Murray, Robin M.
Meyer-Lindenberg, Andreas
Weinberger, Daniel R.
Cannon, Tyrone D.
O'Donovan, Michael
Correll, Christoph U.
Kane, John M.
van Os, Jim
and
Insel, Thomas R.
2015.
Schizophrenia.
Nature Reviews Disease Primers,
Vol. 1,
Issue. 1,
Bhattacharjee, Jayanti
and
El-Sayeh, Hany G
2016.
Aripiprazole versus chlorpromazine for people with schizophrenia and schizophrenia-like psychoses.
Cochrane Database of Systematic Reviews,
Clark, Lee Anna
Cuthbert, Bruce
Lewis-Fernández, Roberto
Narrow, William E.
and
Reed, Geoffrey M.
2017.
Three Approaches to Understanding and Classifying Mental Disorder:ICD-11, DSM-5, and the National Institute of Mental Health’s Research Domain Criteria (RDoC).
Psychological Science in the Public Interest,
Vol. 18,
Issue. 2,
p.
72.
Howard, A.K.
Parfyonov, M.
Wong, V.
and
Zurowski, M.
2017.
Reference Module in Neuroscience and Biobehavioral Psychology.
Cotes, Robert O.
Goldsmith, David R.
Kopelovich, Sarah L.
Lally, Cathy A.
and
Druss, Benjamin G.
2018.
Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy.
Community Mental Health Journal,
Vol. 54,
Issue. 6,
p.
699.
Hui, Christy L M
Honer, William G
Lee, Edwin H M
Chang, Wing Chung
Chan, Sherry K W
Chen, Emily S M
Pang, Edwin P F
Lui, Simon S Y
Chung, Dicky W S
Yeung, Wai Song
Ng, Roger M K
Lo, William T L
Jones, Peter B
Sham, Pak
and
Chen, Eric Y H
2018.
Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.
The Lancet Psychiatry,
Vol. 5,
Issue. 5,
p.
432.
Vantaggiato, Chiara
Panzeri, Elena
Citterio, Andrea
Orso, Genny
and
Pozzi, Marco
2019.
Antipsychotics Promote Metabolic Disorders Disrupting Cellular Lipid Metabolism and Trafficking.
Trends in Endocrinology & Metabolism,
Vol. 30,
Issue. 3,
p.
189.
Benharrats, S.S.
and
Bencharif, M.A.
2019.
Comorbidité schizophrénie et diabète de type 2 en Algérie – étude des facteurs de risque.
Revue d'Épidémiologie et de Santé Publique,
Vol. 67,
Issue. 3,
p.
189.